St. Jude Progress

St. Jude research has advanced understanding of the immune response to SARS-CoV-2 infection and vaccination. Here is what the findings mean for you.

The St. Jude Case Investigation and Contact Tracing Team has been working to keep the St. Jude campus safe during the COVID-19 pandemic.

A pediatric psychologist expresses gratitude for interdisciplinary collaboration, which elevates patient care and provider well-being.

A St. Jude psychologist who provided supportive end-of-life care during the pandemic shares recommendations for making compassionate connections with patients and families.

SAFER Ukraine, a global humanitarian effort to save Ukrainian children with cancer and blood disorders began spontaneously in a digital meeting room within hours of the invasion. Existing networks fueled its growth.

What lessons can be learned from the remarkable success of SAFER Ukraine?

“SAFER Ukraine works because we have human connections with our partners,” explains Asya Agulnik, MD, MPH.

Marcin Wlodarski, MD, PhD, was new to international humanitarian work prior to volunteering with SAFER Ukraine. “I learned so much I cannot every describe it in words,” he said.

Flexible and tailored implementation strategies helped pediatric cancer centers across Latin America scale up a proven quality improvement strategy.

St. Jude scientists have created the first model that faithfully recapitulates details of pediatric bone marrow failure.

Microcephaly is a rare neurodevelopmental condition in which a baby’s head is much smaller than expected because the brain did not develop properly or stopped developing during pregnancy. St. Jude researchers identified cells in the outer radial glia in the developing brain that play an important role in microcephaly.

The incidence of pediatric and adult liver cancer is increasing worldwide. Research suggests how premature birth may influence the risk for children.

The St. Jude Methodist Sickle Cell Disease Transition Clinic helps patients move from pediatric to adult care, an important stage where patients often experience roadblocks to maintaining their health.

Narrative medicines uses insight gained from listening carefully to how patients tell their own stories to improve health care, patient education and research.

May is Brain Tumor Awareness Month and a good time to learn more about the diverse group of diseases that make up the most common childhood solid tumor.

Lessons learned from previous global crises inform the St. Jude Global response to childhood cancer patients displaced by the war in Ukraine.

The 2022 St. Jude Global Alliance Convening brought together researchers from around the globe working to advance cures for children with catastrophic childhood diseases.

Stacey Ogden, PhD, shares mentoring advice for scientists setting up their first laboratory as a principal investigator.

Research suggests the influence of STEM teachers on the STEM identities and attitudes of elementary school students extend to after-school STEM clubs.

Now is a great time for kids to get vaccinated against HPV and protected against six different cancers.

A St. Jude clinical trial launched more than 25 years ago has helped to transform understanding and care for children with the brain tumor craniopharyngioma.

St. Jude scientists are leading research into the genetics of childhood cancer survivorship to understand and prevent the risk of chronic disease in survivors.

Dr. James R. Downing details how St. Jude strategic plan expansion aims to accelerate research and treatment for childhood catastrophic diseases.

Dr. Marta Salek of St. Jude was in Poland visiting family when Russia invaded Ukraine. She jumped in to help launch the humanitarian effort SAFER Ukraine.